Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.

Abstract:

:Bedaquiline is a diarylquinoline antitubercular drug with a novel mechanism of action against Mycobacterium tuberculosis. Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents in more than 40 years. Bedaquiline is indicated for the treatment of multidrug-resistant tuberculosis (MDR TB) in combination with at least three other antitubercular drugs when no other effective regimen is available. The recommended bedaquiline dosage is 400 mg orally once/day for 2 weeks followed by 200 mg orally 3 times/week for 22 weeks. Bedaquiline should be administered with food, which increases the bioavailability 2-fold. Bedaquiline is metabolized by cytochrome P450 isoenzyme 3A4 and is impacted by both inducers and inhibitors of this isoenzyme. Concentration-dependent bactericidal activity was observed in laboratory and murine studies. Accelerated approval was granted in the United States and European Union based on the results of two phase IIb clinical studies that used sputum culture clearance as a surrogate end point for clinical efficacy. These studies showed greater sputum culture clearance up to week 24 for the bedaquiline group compared with placebo. Common adverse events in clinical trials included nausea, arthralgia, and headache. Serious adverse events included elevated serum transaminase levels and rate-corrected QT-interval prolongation. Unexplained higher mortality was seen in patients receiving bedaquiline versus those receiving placebo. Bedaquiline is a novel agent with a unique mechanism of action and has the potential to meet a great need in patients with MDR TB who have no other treatment options. Due to safety concerns and limited clinical information, phase III trials are needed to fully determine its place in therapy.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Worley MV,Estrada SJ

doi

10.1002/phar.1482

subject

Has Abstract

pub_date

2014-11-01 00:00:00

pages

1187-97

issue

11

eissn

0277-0008

issn

1875-9114

journal_volume

34

pub_type

杂志文章,评审
  • Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.

    abstract:STUDY OBJECTIVE:To evaluate the effects of acetaminophen, naproxen, and acetylsalicylic acid on the pharmacokinetics of the centrally acting analgesic tapentadol in healthy subjects. DESIGN:Two randomized, open-label, crossover, drug-drug interaction studies. SETTING:Clinical research facilities in the United States ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.30.1.25

    authors: Smit JW,Oh C,Rengelshausen J,Terlinden R,Ravenstijn PG,Wang SS,Upmalis D,Mangold B

    更新日期:2010-01-01 00:00:00

  • Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin.

    abstract::Fluoxetine hydrochloride is the sixth most prescribed drug in the United States and is administered to treat major depression. A cadaveric skin donation was obtained from a 46-year-old woman who died as a result of a fluoxetine overdose. Due to the potential penetration of the drug and its major metabolite, norfluoxet...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Neudeck BL,Taddonio TE,Garner WL,Welage LS

    更新日期:1998-07-01 00:00:00

  • Cabozantinib: A Multitargeted Oral Tyrosine Kinase Inhibitor.

    abstract::Cabozantinib is an oral small-molecule multitargeted tyrosine kinase inhibitor (TKI) that may confer an advantage over other TKIs that target a single receptor. It was approved by the U.S. Food and Drug Administration for the treatment of both advanced renal cell carcinoma and progressive metastatic medullary thyroid ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2076

    authors: Markowitz JN,Fancher KM

    更新日期:2018-03-01 00:00:00

  • Vancomycin assay performance in patients with end-stage renal disease receiving hemodialysis.

    abstract:STUDY OBJECTIVE:To compare the performance of polyclonal fluorescence polarization immunoassay (pFPIA) with that of enzyme-multiplied immunoassay technique (EMIT) in patients receiving vancomycin and hemodialysis. SETTING:Outpatient hemodialysis center. PATIENTS:Seven subjects with end-stage renal disease treated wit...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.7.653.35177

    authors: Kingery JR,Sowinski KM,Kraus MA,Klaunig JE,Mueller BA

    更新日期:2000-06-01 00:00:00

  • Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.

    abstract::Nucleoside analogs (zidovudine, didanosine, zalcitabine, stavudine, abacavir, lamivudine) have been administered as antiretroviral agents for more than a decade. They undergo anabolic phosphorylation by intracellular kinases to form triphosphates, which inhibit human immunodeficiency virus replication by competitively...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.1.11.34439

    authors: Stein DS,Moore KH

    更新日期:2001-01-01 00:00:00

  • Renal function and methotrexate clearance in children with newly diagnosed leukemia.

    abstract:STUDY OBJECTIVES:To determine whether glomerular filtration rate (GFR) changes during induction chemotherapy in children with leukemia, and to examine GFR as a determinant of pharmacokinetic variability of methotrexate clearance. DESIGN:Prospective, unblinded observational study in consecutive patients. SETTING:A res...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Murry DJ,Synold TW,Pui CH,Rodman JH

    更新日期:1995-03-01 00:00:00

  • Retrospective evaluation of the conversion of amlodipine to alternative calcium channel blockers.

    abstract:STUDY OBJECTIVE:To evaluate the effectiveness, safety, and costs associated with a formulary conversion from amlodipine to alternative calcium channel blockers. DESIGN:Retrospective study. SETTING:Veterans Affairs Medical Center. PATIENTS:One hundred patients with hypertension who were receiving amlodipine. INTERVE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.13.1072.35022

    authors: Parra D,Beckey NP,Korman L

    更新日期:2000-09-01 00:00:00

  • Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists.

    abstract::A formerly infrequently isolated strain of Clostridium difficile known as BI/NAP1 has resulted in geographically diverse outbreaks of C. difficile-associated disease. Such rapid dissemination and distribution of an outbreak strain of C. difficile are unprecedented, with many regions across North America, as well as se...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.3.299

    authors: Owens RC

    更新日期:2006-03-01 00:00:00

  • Novel oral anticoagulants and their role in clinical practice.

    abstract::The complexities of oral anticoagulation with warfarin have led to the search for more practical alternative agents. Novel direct factor IIa inhibitors and direct factor Xa inhibitors currently in development can be administered at a fixed dose and do not require routine coagulation monitoring and ongoing dosage adjus...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.12.1175

    authors: Wittkowsky AK

    更新日期:2011-12-01 00:00:00

  • Decreased methadone effect after ritonavir initiation.

    abstract::Combination antiretroviral therapy including protease inhibitors such as ritonavir has added significant potency to therapy for human immunodeficiency viral (HIV) infection as well as substantial drug-drug interactions. Methadone metabolism is affected by cytochrome P450 (CYP) 3A4 inhibitors or inducers. Because riton...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.1.93.34654

    authors: Geletko SM,Erickson AD

    更新日期:2000-01-01 00:00:00

  • Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease.

    abstract::Graves' disease is an autoimmune process in which the thyroid gland is stimulated by autoantibodies, leading to hyperthyroidism. Graves' disease is the most common cause of hyperthyroid function, primarily affecting women in their 40s and 50s. Treatment may involve oral radioiodine, which is taken up by the follicular...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.7.1017

    authors: Kolade VO,Bosinski TJ,Ruffy EL

    更新日期:2005-07-01 00:00:00

  • Identification of a gemcitabine-warfarin interaction.

    abstract::A man anticoagulated with warfarin 57.5 mg/week (international normalized ratio [INR] 1.94) was diagnosed with nonsmall cell lung cancer and prescribed weekly gemcitabine. With the first dose of the first cycle, his INR rose to 3.52, and his weekly warfarin dose was decreased to 52.5 mg. The lower warfarin dose was co...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.16.1331.30873

    authors: Kinikar SA,Kolesar JM

    更新日期:1999-11-01 00:00:00

  • Ceftaroline-induced eosinophilic pneumonia.

    abstract::We present a case of eosinophilic pneumonia due to ceftaroline used for the treatment of methicillin-resistant Staphylococcus aureus bacteremia associated with a postoperative spinal infection. Our patient developed shortness of breath and hypoxemia on the fifth week of ceftaroline therapy. Chest imaging disclosed dif...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1286

    authors: Desai KR,Burdette SD,Polenakovik HM,Hagaman J,Pleiman CM

    更新日期:2013-07-01 00:00:00

  • Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate.

    abstract::Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL), which is a subtype of non-Hodgkin lymphoma, are relatively uncommon lymphoproliferative types of cancer. These malignancies are highly curable with initial treatment. Nonetheless, some patients are refractory to or relapse after first- and seco...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1170

    authors: Newland AM,Li JX,Wasco LE,Aziz MT,Lowe DK

    更新日期:2013-01-01 00:00:00

  • Reteplase for dysfunctional hemodialysis catheter clearance.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy of reteplase administration in clearing hemodialysis catheters. DESIGN:Open-label, uncontrolled, observational trial. SETTING:University medical center. PATIENTS:Thirty-four patients with end-stage renal disease undergoing long-term hemodialysis. INTERVENTION:Patients had du...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.23.2.137.32086

    authors: Hilleman DE,Dunlay RW,Packard KA

    更新日期:2003-02-01 00:00:00

  • Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-americans with hypertension using 24-hour ambulatory blood pressure monitoring.

    abstract:STUDY OBJECTIVE:To compare the efficacy of amlodipine and valsartan in African-American patients with hypertension using ambulatory blood pressure monitoring (ABPM). DESIGN:Prospective, randomized, double-blind, crossover comparison study. SETTING:University-affiliated cardiac center clinic. PATIENTS:Twenty African-...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1592/phco.26.7.889

    authors: Maciejewski S,Mohiuddin SM,Packard KA,Mooss AN,Reyes AP,Aryana A,Hilleman DE

    更新日期:2006-07-01 00:00:00

  • Postinduction carbamazepine clearance in an adult psychiatric population.

    abstract::The objective of this study was to describe the postinduction clearance of carbamazepine (CBZ) in adult psychiatric patients by population pharmacokinetic analysis using the NONMEM program. Specifically, an estimate of CBZ clearance and insight into the effect of common patient characteristics on clearance were sought...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Martin ES 3rd,Crismon ML,Godley PJ

    更新日期:1991-01-01 00:00:00

  • Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.

    abstract:STUDY OBJECTIVES:To determine changes in bone mineral density (BMD) and T scores of patients after 2 years of teriparatide therapy, and to determine the number of fractures that occurred during therapy. DESIGN:Prospective, observational study. SETTING:Pharmacist-run teriparatide clinic in a private-practice endocrino...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.27.6.779

    authors: Stroup JS,Rivers SM,Abu-Baker AM,Kane MP

    更新日期:2007-06-01 00:00:00

  • Treatment options for nausea and vomiting during pregnancy.

    abstract::Nausea and vomiting, common symptoms during pregnancy, often are regarded as an unpleasant but normal part of pregnancy during the first and early second trimesters. Nausea and vomiting of pregnancy (NVP) occurs in approximately 75-80% of pregnant women. The exact etiology and pathogenesis of NVP are poorly understood...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.9.1273

    authors: Badell ML,Ramin SM,Smith JA

    更新日期:2006-09-01 00:00:00

  • Physician-pharmacist collaborative management of asthma in primary care.

    abstract:OBJECTIVE:To determine if asthma control improves in patients who receive physician-pharmacist collaborative management (PPCM) during visits to primary care medical offices. DESIGN:Prospective pre-post study of patients who received the intervention in primary care offices for 9 months. The primary outcome was the sum...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1468

    authors: Gums TH,Carter BL,Milavetz G,Buys L,Rosenkrans K,Uribe L,Coffey C,MacLaughlin EJ,Young RB,Ables AZ,Patel-Shori N,Wisniewski A

    更新日期:2014-10-01 00:00:00

  • Key articles and guidelines in the management of hypertension: 2008 update.

    abstract::Hypertension remains a major risk factor for cardiovascular disease. The optimal choice of pharmacologic and nonpharmacologic treatment regimens is based on a plethora of published literature. This compilation is the initial update to the Key Articles and Guidelines in the Management of Hypertension authored by member...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.8.1041

    authors: Gaffney SM,de Denus S,Olson KL,Ripley TL,Robinette B,Summers KM,Spencer AP

    更新日期:2008-08-01 00:00:00

  • Can the frequency and risks of fatal adverse drug events be determined?

    abstract::Death is the ultimate adverse drug event. Despite its importance, the frequency of fatal adverse drug events is unknown. Estimates in the United States are as high as 140,000/year, although this number is heavily disputed. Potential reasons and risks for fatal adverse drug events, as well as epidemiologic designs for ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.6.521.34540

    authors: Kelly WN

    更新日期:2001-05-01 00:00:00

  • Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients.

    abstract:STUDY OBJECTIVES:To evaluate the safety and efficacy of aerosolized ceftazidime for prevention of ventilator-associated pneumonia (VAP) and to evaluate the effects of the drug on the proinflammatory response. DESIGN:Prospective, randomized, double-blind, placebo-controlled clinical trial. SETTING:University teaching ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.22.12.972.33596

    authors: Wood GC,Boucher BA,Croce MA,Hanes SD,Herring VL,Fabian TC

    更新日期:2002-08-01 00:00:00

  • Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program.

    abstract::Our objective was to describe the implementation and clinical outcomes of an employer-sponsored, pharmacist-provided medication therapy management (MTM) program for health plan beneficiaries with diabetes mellitus and/or hypertension. We conducted a single-center retrospective medical record review. The setting was a ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1650

    authors: Theising KM,Fritschle TL,Scholfield AM,Hicks EL,Schymik ML

    更新日期:2015-11-01 00:00:00

  • Prepharmacy predictors of success in pharmacy school: grade point averages, pharmacy college admissions test, communication abilities, and critical thinking skills.

    abstract::Good admissions decisions are essential for identifying successful students and good practitioners. Various parameters have been shown to have predictive power for academic success. Previous academic performance, the Pharmacy College Admissions Test (PCAT), and specific prepharmacy courses have been suggested as acade...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.9.842.34566

    authors: Allen DD,Bond CA

    更新日期:2001-07-01 00:00:00

  • CYP2D6, N-acetylation, and xanthine oxidase activity in cystic fibrosis.

    abstract:STUDY OBJECTIVE:To determine the activity of CYP2D6, N-acetylation, and xanthine oxidase, three drug-metabolizing enzyme systems, in patients with cystic fibrosis and compare the findings with those in individuals without the disease. DESIGN:Prospective cohort study. SETTING:General pediatrics service. PATIENTS:Fift...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Bosso JA,Liu Q,Evans WE,Relling MV

    更新日期:1996-09-01 00:00:00

  • Acute ischemic stroke update.

    abstract::Stroke is the third most common cause of death in the United States and is the number one cause of long-term disability. Legislative mandates, largely the result of the American Heart Association, American Stroke Association, and Brain Attack Coalition working cooperatively, have resulted in nationwide standardization...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.5.493

    authors: Baldwin K,Orr S,Briand M,Piazza C,Veydt A,McCoy S

    更新日期:2010-05-01 00:00:00

  • Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.

    abstract::Disseminated herpes simplex virus (HSV) infection in neonates represents a devastating entity that yields high mortality. Acyclovir is the primary antiviral agent used to treat life-threatening HSV infections in neonates; however, even though the agent has reduced morbidity overall from these infections, mortality wit...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1526

    authors: Cies JJ,Moore WS 2nd,Miller K,Small C,Carella D,Conley S,Parker J,Shea P,Chopra A

    更新日期:2015-02-01 00:00:00

  • Periodontal disease and atherosclerotic cardiovascular disease: confounding effects or epiphenomenon?

    abstract::Recent evidence suggests that periodontal disease may predispose to atherosclerotic cardiovascular disease. Data support mechanisms of host-derived local and systemic proinflammatory responses similar to atherosclerosis, consisting of monocytic-derived cytokines and other inflammatory mediators, which are induced by p...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.9.805.35189

    authors: Chong PH,Kezele B

    更新日期:2000-07-01 00:00:00

  • Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.

    abstract::The prevalence of diabetes mellitus has grown to staggering numbers, and its incidence is expected to rise in the next 2 decades. The need for novel approaches to treat hyperglycemia cannot be ignored. Current agents have been shown to modestly improve glycemia and in some cases prevent complications of diabetes, but ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/PHAR.1010

    authors: Shah NK,Deeb WE,Choksi R,Epstein BJ

    更新日期:2012-01-01 00:00:00